Image

Evaluating Autologous Stromal Vascular Fraction in Subjects With Vocal Fold Scar

Evaluating Autologous Stromal Vascular Fraction in Subjects With Vocal Fold Scar

Non Recruiting
18-80 years
All
Phase 1

Powered by AI

Overview

The purpose of this research study is to assess if autologous Stromal Vascular Fraction (SVF) taken from the stomach or hips can help heal vocal fold scars.

Eligibility

Inclusion Criteria:

  • Signed informed consent
  • Subject's age between 18 and < 80-years-old
  • Voice handicap index greater than 10/40
  • Scarred vocal folds or congenital sulcus or after vocal fold surgery (Scarring will be scored during examination and identification of scarred vocal folds and hoarseness. This criterion includes the lack of or decreased mucosal wave of the vocal fold during videostroboscopy exam. Scoring of scar based on laryngoscopic exam: Type I: atrophy of lamina propria with/without affected epithelium. Type II: the epithelium, lamina propria, and muscle are affected. Type III: scar located on the anterior commissure. Type IV: this category includes extended scar formation in both anteroposterior and rostro-caudal axis, with significant loss of vocal fold mass)
  • Unilateral or Bilateral vocal fold scarring
  • At least 1-year delay after initial surgery
  • Negative pregnancy test and contraception for woman of childbearing age. Women of childbearing age must use contraception at least 4 months pre and post SVF administration.

Exclusion Criteria:

  • Refusal of speech therapy
  • History of malignant lesion or severe dysplasia of the scarred vocal fold
  • Contraindication to anesthesia, anticoagulant treatment, coagulation disorders, active infectious disease
  • Refusal or inability to comply with study procedures
  • Pregnant and lactating woman
  • Major chronic medical condition that could affect treatment or quality of SVF product. These include:
    • Current treatment or within 6 months of last treatment for cancer.
    • Blindness
    • Known history of Dementia,
    • Known history of Kidney Disease
    • Known history of Cerebral Vascular Accident or Stroke
  • Known history of Diabetes
  • Abnormal screening lab. If the laboratory reports a single, non-clinically relevant, non-life-threatening result for any of these studies and is the only excluding factor it may be repeated 1 week later if the subject wishes. Normalization of that laboratory study will then be considered non-exclusionary.
  • Post-Radiation scarring of vocal folds.

Study details
    Vocal Fold Scars

NCT05354544

Shane A. Shapiro

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.